Compounds > 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Vomiting

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Vomiting in 1 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cox, H1
Togasaki, DM1
Chen, L1
Langston, JW1
Di Monte, DA1
Quik, M1

Other Studies

1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Vomiting

ArticleYear
The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates.
    Experimental neurology, 2007, Volume: 205, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl

2007